Retransplantation for recurrent hepatitis C: Positive aspects

Research output: Contribution to journalArticle

28 Scopus citations

Abstract

Key Points 1. The prevalence of retransplantation for hepatitis C (HCV) patients is stable (around 40%). 2. Survival models to predict outcome of retransplantation do not show that HCV is an independent variable with poor outcomes. 3. Using Model for End-Stage Liver Disease (MELD) scores from the United Network for Organ Sharing (UNOS) database from 1996-2002, retransplantation for HCV had similar outcomes to other causes of retransplantation. 4. Poorer outcomes were noted for retransplantation with MELD scores greater than 25. 5. Minimal survival thresholds need to be developed for retransplantation for all causes of retransplantation.

Original languageEnglish (US)
Pages (from-to)S67-S72
JournalLiver Transplantation
Volume9
Issue number11
DOIs
StatePublished - Nov 2003

    Fingerprint

ASJC Scopus subject areas

  • Surgery
  • Hepatology
  • Transplantation

Cite this